Inflammatory Mediators

Sepsis and Non-Infectious Systemic Inflammation: From Biology to Critical Care

Volumn , Issue , 2009, Pages 175-204

  Philippart, François ^a,b   Cavaillon, Jean Marc ^a   Dinarello, Charles ^c  

^a INSTITUT PASTEUR   (France)

^b SAINT JOSEPH HOSPITAL   (France)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cellular markers; Complement system; Cytokines; Growth factor; Inflammatory mediators; Lipid mediators; Nitric oxide (NO)

Indexed keywords

EID: 84889401385     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527626151.ch8     Document Type: Chapter

References (133)

1. Cavaillon, J.M., Adib-Conquy, M., Fitting, C., Adrie, C. and Payen, D. (2003). Cytokine cascade in sepsis. Scand. J. Infect. Dis., 35(9), 9-535.
2. Suntharalingam, G., Perry, M.R., Ward, S., Brett, S.J., Castello-Cortes, A., Brunner, M.D., et al. (2006). Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med., 355(10), 10-1018.
3. Granger, J. and Remick, D. (2005). Acute pancreatitis: models, markers, and mediators. Shock, 24(Suppl 1), 45-51.
4. Cavaillon, J.M., Munoz, C., Fitting, C., Misset, B. and Carlet, J. (1992). Circulating cytokines: the tip of the iceberg?. Circ. Shock, 38(2), 2-145.
5. Munoz, C., Misset, B., Fitting, C., Bleriot, J.P., Carlet, J. and Cavaillon, J.M. (1991). Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur. J. Immunol., 21(9), 9-2177.
6. Pinsky, M.R., Vincent, J.L., Deviere, J., Alegre, M., Kahn, R.J. and Dupont, E. (1993). Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest, 103(2), 2-565.
7. Hildebrand, F., Stuhrmann, M., van Griensven, M., Meier, S., Hasenkamp, S., Krettek, C., et al. (2007). Association of IL-8-251A/T polymorphism with incidence of Acute Respiratory Distress Syndrome (ARDS) and IL-8 synthesis after multiple trauma. Cytokine., 37(3), 3-192.
8. Sappington, P.L., Yang, R., Yang, H., Tracey, K.J., Delude, R.L. and Fink, M.P. (2002). HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology, 123(3), 3-790.
9. Amiot, F., Fitting, C., Tracey, K.J., Cavaillon, J.M. and Dautry, F. (1997). Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice. Mol Med.,. (12) , 864-75.
10. Michie, H.R., Manogue, K.R., Spriggs, D.R., Revhaug, A., O'Dwyer, S. and Dinarello, C.A., et al. (1988). Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med., 318(23), 23-1481.
11. Vermont, C.L., Hazelzet, J.A., de Kleijn, E.D., van den Dobbelsteen, G.P. and deGroot, R. (2006). CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity. Crit. Care., 10(1), R33.
12. Moreno, S.E., Alves-Filho, J.C., Alfaya, T.M., da Silva, J.S., Ferreira, S.H. and Liew, F.Y. (2006). IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J. Immunol., 177(5), 5-3218.
13. Hiromatsu, T., Yajima, T., Matsuguchi, T., Nishimura, H., Wajjwalku, W. and Arai, T., et al. (2003). Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. J. Infect. Dis., 187(9), 9-1442.
14. Netea, M.G., Fantuzzi, G., Kullberg, B.J., Stuyt, R.J., Pulido, E.J. and McIntyre, R.C., Jr., et al. (2000). Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J. Immunol., 164(5), 5-2644.
15. Hochholzer, P., Lipford, G.B., Wagner, H., Pfeffer, K. and Heeg, K. (2000). Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect. Immun., 68(6), 6-3502.
16. Tschoeke, S.K., Oberholzer, A. and Moldawer, L.L. (2006). Interleukin-18:a novel prognostic cytokine in bacteria-induced sepsis. Crit. Care. Med., 34(4), 4-1225.
17. Feezor, R.J., Oberholzer, C., Baker, H.V., Novick, D., Rubinstein, M., Moldawer, L.L., et al. (2003). Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect. Immun., 71(10), 10-5803.
18. Belladonna, M.L., Vacca, C., Volpi, C., Giampietri, A., Fioretti, M.C., Puccetti, P., et al. (2006). IL-23 neutralization protects mice from Gram-negative endotoxic shock. Cytokine., 34(3-4), 161-9.
19. Wirtz, S., Tubbe, I., Galle, P.R., Schild, H.J., Birkenbach, M. and Blumberg, R.S., et al. (2006). Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J. Exp. Med., 203(8), 8-1875.
20. Sweet, M.J., Leung, B.P., Kang, D., Sogaard, M., Schulz, K. and Trajkovic, V., et al. (2001). A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol., 166(11), 11-6633.
21. Qiu, G., Gribbin, E., Harrison, K., Sinha, N. and Yin, K. (2003). Inhibition of gamma interferon decreases bacterial load in peritonitis by accelerating peritoneal fibrin deposition and tissue repair. Infect. Immun., 71(5), 5-2766.
22. Echtenacher, B., Freudenberg, M.A., Jack, R.S. and Mannel, D.N. (2001). Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect. Immun., 69(12), 12-7271.
23. Yin, K., Gribbin, E. and Wang, H. (2005). Interferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats: implication of high mobility group box-1. Shock., 24(4), 4-396.
24. Calandra, T., Echtenacher, B., Roy, D.L., Pugin, J., Metz, C.N. and Hultner, L., et al. (2000). Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med., 6(2), 2-164.
25. Matsuda, N., Nishihira, J., Takahashi, Y., Kemmotsu, O. and Hattori, Y. (2006). Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia. Am. J. Respir. Cell. Mol. Biol., 35(2), 2-198.
26. VanOtteren, G.M., Strieter, R.M., Kunkel, S.L., Paine, R, Greenberger M.J, Danforth J.M., et al. (1995). Compartmentalized expression of RANTES in a murine model of endotoxemia. J. Immunol., 154(4), 4-1900.
27. Imhof, B.A. and Aurrand-Lions, M. (2004). Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol., 4(6), 6-432.
28. Kaneider, N.C., Agarwal, A., Leger, A.J. and Kuliopulos, A. (2005). Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat. Med., 11(6), 6-661.
29. Netea, M.G., Joosten, L.A., Lewis, E., Jensen, D.R., Voshol, P.J. and Kullberg, B.J., et al. (2006). Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat. Med., 12(6), 6-650.
30. Yano, K., Liaw, P.C., Mullington, J.M., Shih, S.C., Okada, H., Bodyak, N., et al. (2006). Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J. Exp. Med., 203(6), 6-1447.
31. Haeffner-Cavaillon, N., Cavaillon, J.M., Laude, M. and Kazatchkine, M.D. (1987). C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J. Immunol., 139(3), 3-794.
32. Cavaillon, J.M., Fitting, C. and Haeffner-Cavaillon, N. (1990). Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur. J. Immunol., 20(2), 2-253.
33. Niederbichler, A.D., Hoesel, L.M., Westfall, M.V., Gao, H., Ipaktchi, K.R., Sun, L., et al. (2006). An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J. Exp. Med., 203(1), 1-53.
34. Ward, P.A. (2004). The dark side of C5a in sepsis. Nat. Rev. Immunol., 4(2), 2-133.
35. Liu, D., Zhang, D., Scafidi, J.,Wu, X., Cramer, C.C., Davis, A.E, (2005). C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability. Blood., 105(6), 6-2350.
36. Liu, D., Cai, S., Gu, X., Scafidi, J., Wu, X., Davis, A.E, . (2003). C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J. Immunol., 171(5), 5-2594.
37. Osterud, B., Flaegstad, T. (1983). Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb. Haemost., 49(1), 1-5.
38. Zeerleder, S., Schroeder, V., Lammle, B., Wuillemin, W.A., Hack, C.E. and Kohler,H.P. (2007). Factor XIII in severe sepsis and septic shock. Thromb. Res., 119(3), 3-311.
39. Bernard, G.R., Vincent, J.L., Laterre, P.F., LaRosa, S.P., Dhainaut, J.F., Lopez-Rodriguez, A., et al. (2001). Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med., 344(10), 10-699.
40. Yan, S.B., Helterbrand, J.D., Hartman, D.L., Wright, T.J. and Bernard, G.R. (2001). Low levels of protein C are associated with poor outcome in severe sepsis. Chest., 120(3), 3-915.
41. Murakami, K., Okajima, K., Uchiba, M., Johno, M., Nakagaki, T., Okabe, H., et al. (1997). Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am. J. Physiol., 272(2 Pt 1), L197-202.
42. Esmon, C. (2000). The protein C pathway. Crit. Care. Med., 28(9 Suppl), S44-8.
43. Becker, R.C. (2002). Antithrombotic therapy after myocardial infarction. N. Engl. J. Med., 347(13), 13-1019.
44. Verbon, A., Meijers, J.C., Spek, C.A., Hack, C.E., Pribble, J.P., Turner, T., et al. (2003). Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans. J. Infect. Dis., 187(1), 1-55.
45. Madoiwa, S., Nunomiya, S., Ono, T., Shintani, Y., Ohmori, T.,Mimuro, J., et al. (2006). Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation. Int. J. Hematol., 84(5), 5-398.
46. Renckens, R., Roelofs, J.J., Bonta, P.I., Florquin, S., de Vries, C.J., Levi, M., et al. (2007). Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood., 109(4), 4-1593.
47. Nakamura, A., Mori, Y., Hagiwara, K., Suzuki, T., Sakakibara, T., Kikuchi, T., et al. (2003). Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J. Exp. Med., 197(5), 5-669.
48. Renckens, R., Roelofs, J.J., Florquin, S., de Vos, A.F., Lijnen, H.R., van't Veer, C., et al. (2006). Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J. Immunol., 176(6), 6-3735.
49. Yassen, K.A., Galley, H.F., Webster, N.R. (2001). Matrix metalloproteinase-9 concentrations in critically ill patients. Anaesthesia., 56(8), 8-729.
50. Benjamim, C.F., Canetti, C., Cunha, F.Q., Kunkel, S.L., Peters-Golden, M. (2005). Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis. J. Immunol., 174(3), 3-1616.
51. Ejima, K., Layne, M.D., Carvajal, I.M., Kritek, P.A., Baron, R.M., Chen, Y.H., et al. (2003). Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J., 17(10), 10-1325.
52. Bernard, G.R W.A., Russell, J.A., Schein, R., Summer, W.R., Steinberg, K.P., Fulkerson, W.J., Wright, P.E., Christman, B.W., Dupont, W.D., Higgins, S.B., Swindell, B.B. (1997). The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N. Engl. J. Med., 336(13), 13-912.
53. Gomes, R.N., Bozza, F.A., Amancio, R.T., Japiassu, A.M., Vianna, R.C., Larangeira, A.P., et al. (2006). Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock., 26(1), 1-41.
54. Annane, D., Sanquer, S., Sebille, V., Faye, A., Djuranovic, D., Raphael, J.C., et al. (2000). Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet., 355(9210), 9210-1143.
55. Asakura, H., Asamura, R., Ontachi, Y., Hayashi, T., Yamazaki, M., Morishita, E., et al. (2005). Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats. J. Thromb. Haemost., 3(5), 5-1050.
56. Benjamim, C.F., Silva, J.S., Fortes, Z.B., Oliveira, M.A., Ferreira, S.H., Cunha, F.Q. (2002). Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect. Immun., 70(7), 7-3602.
57. Matejovic, M., Krouzecky, A., Radej, J., Rokyta, R., Jr., Kralova H, Radermacher P., et al. (2007). Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia-effects of selective inducible nitric oxide synthase inhibition. Thromb. Haemost., 97(2), 2-304.
58. Han, X., Fink, M.P., Uchiyama, T., Yang, R., Delude, R.L. (2004). Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice. Am. J. Physiol. Lung. Cell. Mol. Physiol., 286(2), L259-67.
59. Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H.E., et al. (2004). Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA., 101(1), 1-296.
60. Angus, D.C., Yang, L., Kong, L., Kellum, J.A., Delude, R.L., Tracey, K.J., et al. (2007). Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit. Care. Med., 35(4), 4-1061.
61. Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink,M.P., Lotze, M.T., et al. (2005). The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med., 201(7), 7-1135.
62. Qin, S., Wang,H., Yuan, R., Li,H., Ochani, M., Ochani, K., et al. (2006). Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med., 203(7), 7-1637.
63. Bouchon, A., Facchetti, F., Weigand,M.A., Colonna,M. (2001). TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature., 410(6832), 6832-1103.
64. Adib-Conquy, M., Monchi, M., Goulenok, C., Laurent, I., Thuong, M., Cavaillon, J.M. and Adrie, C. (2007). Enhanced plasma levels of soluble triggering expressed on myeloid cells-1 and procalcitonin after cardiac surgery and cardiac arrest in the absence of infection. Shock.
65. Moestrup, S.K., Moller, H.J. (2004). CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann. Med., 36(5), 5-347.
66. Imai, T., Fujita, T., Yamazaki, Y. (2003). Beneficial effects of apolipoprotein A-I on endotoxemia. Surg. Today., 33(9), 9-684.
67. Jacque, B., Stephan, K., Smirnova, I., Kim, B., Gilling, D., Poltorak, A. (2006). Mice expressing high levels of soluble CD14 retain LPS in the circulation and are resistant to LPS-induced lethality. Eur. J. Immunol., 36(11), 11-3007.
68. Munford, R.S., Pugin, J. (2001). Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am. J. Respir. Crit. Care. Med., 163(2), 2-316.
69. Marchant, A., Bruyns, C., Vandenabeele, P., Ducarme, M., Gerard, C., Delvaux, A., et al. (1994). Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol., 24(5), 5-1167.
70. Marie, C., Cavaillon, J.M., Losser, M.R. (1996). Elevated levels of circulating transforming growth factor-beta 1 in patients with the sepsis syndrome. Ann. Intern. Med., 125(6), 6-520.
71. Girardin, E., Roux-Lombard, P., Grau, G.E., Suter, P., Gallati, H., Dayer, J.M. (1992). Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. Immunology., 76(1), 1-20.
72. van Deuren, M., van der Ven-Jongekrijg, J., Vannier, E., van Dalen, R., Pesman, G., Bartelink, A.K., et al. (1997). The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood., 90(3), 3-1101.
73. Fischer, E., Van Zee, K.J., Marano, M.A., Rock, C.S., Kenney, J.S., Poutsiaka, D.D., et al. (1992). Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood., 79(9), 9-2196.
74. Novick, D., Schwartsburd, B., Pinkus, R., Suissa, D., Belzer, I., Sthoeger, Z., et al. (2001). A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine., 14(6), 6-334.
75. Granowitz, E.V., Santos, A.A., Poutsiaka, D.D., Cannon, J.G., Wilmore, D.W., Wolff, S.M., et al. (1991). Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet., 338(8780), 8780-1423.
76. Wakabayashi, G., Gelfand, J.A., Jung, W.K., Connolly, R.J., Burke, J.F., Dinarello, C.A. (1991). Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J. Clin. Invest., 87(6), 6-1925.
77. Mancilla, J., Garcia, P., Dinarello, C.A. (1993). The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats. Infect. Immun., 61(3), 3-926.
78. Pathan, N., Hemingway, C.A., Alizadeh, A.A., Stephens, A.C., Boldrick, J.C., Oragui, E.E., et al. (2004). Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet., 363(9404), 9404-203.
79. Witzenbichler, B., Westermann, D., Knueppel, S., Schultheiss, H.P., Tschope, C. (2005). Protective role of angiopoietin-1 in endotoxic shock. Circulation., 111(1), 1-97.
80. Orfanos, S.E., Kotanidou, A., Glynos, C., Athanasiou, C., Tsigkos, S., Dimopoulou, I., et al. (2007). Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit. Care. Med., 35(1), 1-199.
81. Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., et al. (2005). Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature., 436(7047), 7047-112.
82. Schindler, R.DC., Koch, K.M. (1995). Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells. Cytokine., 7(6), 6-526.
83. Faggioni, R., Fantuzzi, G., Gabay, C., Moser, A., Dinarello, C.A., Feingold, K.R., et al. (1999). Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am. J. Physiol., 276(1 Pt 2), R136-42.
84. Puneet, P., Hegde, A., Ng, S.W., Lau, H.Y., Lu, J., Moochhala, S.M., et al. (2006). Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis. J. Immunol., 176(6), 6-3813.
85. Deng, J., Muthu, K., Gamelli, R., Shankar, R., Jones, S.B. (2004). Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis. Am. J. Physiol. Cell. Physiol., 287(3), C730-6.
86. Wong, L.Y., Cheung, B.M., Li, Y.Y., Tang, F. (2005). Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. Endocrinology., 146(3), 3-1321.
87. Borovikova, L.V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G.I., Watkins, L.R., et al. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature., 405(6785), 6785-458.
88. Pavlov, V.A., Ochani, M., Gallowitsch-Puerta, M., Ochani, K., Huston, J.M., Czura, C.J., et al. (2006). Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl. Acad. Sci. USA., 103(13), 13-5219.
89. Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu. Rev. Immunol., 12, 991-1045.
90. Oppenheim, J.J., Yang, D. (2005). Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol., 17(4), 4-359.
91. Bianchi, M.E. (2007). DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol., 81(1), 1-1.
92. Muir, K.W., Tyrrell, P., Sattar, N., Warburton, E. (2007). Inflammation and ischaemic stroke. Curr. Opin. Neurol., 20(3), 3-334.
93. Tousoulis, D., Antoniades, C., Koumallos, N., Stefanadis, C. (2006). Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev., 17(4), 4-225.
94. Miki, C., Iriyama, K., Gunson, B.K., Mayer, A.D., Buckels, J.A., McMaster, P. (1997). Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. Arch. Surg., 132(2), 2-136.
95. Hennein, H.A., Ebba, H., Rodriguez, J.L., Merrick, S.H., Keith, F.M., Bronstein, M.H., et al. (1994). Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J. Thorac. Cardiovasc. Surg., 108(4), 4-626.
96. Khabar, K.S., el Barbary, M.A., Khouqeer, F., Devol, E., al-Gain, S., al-Halees, Z. (1997). Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin. Immunol. Immunopathol., 85(1), 1-97.
97. Cruickshank, A.M., Fraser, W.D., Burns, H.J., Van Damme, J., Shenkin, A. (1990). Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin. Sci. (Lond)., 79(2), 2-161.
98. Gueugniaud, P.Y., Bertin-Maghit, M., Hirschauer, C., Bouchard, C., Vilasco, B., Petit, P. (1997) In the early stage ofmajor burns, is there a correlation between survival, interleukin-6 levels and oxygen delivery and consumption? Burns., 23(5), 426-31.
99. Geppert, A., Dorninger, A., Delle-Karth, G., Zorn, G., Heinz, G., Huber, K. (2006). Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit. Care. Med., 34(8), 8-2035.
100. Waydhas, C., Nast-Kolb, D., Jochum, M., Trupka, A., Lenk, S., Fritz, H., et al. (1992). Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch. Surg., 127(4), 4-460.
101. Fassbender, K., Rossol, S., Kammer, T., Daffertshofer, M., Wirth, S., Dollman, M., et al. (1994). Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J. Neurol. Sci., 122(2), 2-135.
102. de Beaux, A.C., Ross, J.A., Maingay, J.P., Fearon, K.C., Carter, D.C. (1996). Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br. J. Surg., 83(8), 8-1071.
103. Riche, F., Dosquet, C., Panis, Y., Valleur, P., Laisne, M.J., Briard, C., et al. (1995). Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease. J. Am. Coll. Surg., 180(6), 6-718.
104. Miyao, Y., Miyazaki, S., Goto, Y., Itoh, A., Daikoku, S., Morii, I., et al. (1999). Role of cytokines and adhesion molecules in ischemia and reperfusion in patients with acute myocardial infarction. Jpn. Circ. J., 63(5), 5-362.
105. Nathan, N., Denizot, Y., Cornu, E., Jauberteau, M.O., Chauvreau, C., Feiss, P. (1997). Cytokine and lipid mediator blood concentrations after coronary artery surgery. Anesth. Analg., 85(6), 6-1240.
106. Saatvedt, K., Lindberg, H., Michelsen, S., Pedersen, T., Seem, E., Geiran, O. (1996). Release of soluble tumour necrosis factor alpha receptors during and after paediatric cardiopulmonary bypass. Correlation with haemodynamic and clinical variables. Cytokine., 8(12), 12-944.
107. Ikei, S., Ogawa, M., Yamaguchi, Y. (1998). Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis. J. Gastroenterol. Hepatol., 13(12), 12-1274.
108. Gross, V., Andreesen, R., Leser, H.G., Ceska, M., Liehl, E., Lausen, M., et al. (1992). Interleukin-8 and neutrophil activation in acute pancreatitis. Eur. J. Clin. Invest., 22(3), 3-200.
109. Pezzilli, R., Billi, P., Miniero, R., Fiocchi, M., Cappelletti, O., Morselli-Labate, A.M., et al. (1995). Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig. Dis. Sci., 40(11), 11-2341.
110. Kossmann, T., Hans, V.H., Imhof, H.G., Stocker, R., Grob, P., Trentz, O., et al. (1995). Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock., 4(5), 5-311.
111. Kawamura, T., Wakusawa, R., Okada, K. and Inada, S. (1993). Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can. J. Anaesth., 40(11), 11-1016.
112. Deng, M.C., Dasch, B., Erren, M., Mollhoff, T., Scheld, H.H. (1996). Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann. Thorac. Surg., 62(1), 1-184.
113. Struzyna, J., Pojda, Z., Braun, B., Chomicka, M., Sobiczewska, E., Wrembel, J. (1995). Serumcytokine levels (IL-4, IL-6, IL-8, G-CSF, preoperative acute phase response and postoperative complications. Eur. J. Surg., 163(1), 1-39.
114. Vindenes, H., Ulvestad, E., Bjerknes, R. (1995). Increased levels of circulating interleukin-8 in patients with large burns: relation to burn size and sepsis. J. Trauma., 39(4), 4-635.
115. Silva-Mejias, C., Gamboa-Antinolo, F., Lopez-Cortes, L.F., Cruz-Ruiz, M., Pachon, J. (1995). Interleukin-1 beta in pleural fluids of different etiologies: its role as inflammatory mediator in emphysema. Chest., 108(4), 4-942.
116. Povoa, P. (2002). C-reactive protein: a valuable marker of sepsis. Intensive Care. Med., 28(3), 3-235.
117. Meisner, M. (2005). Biomarkers of sepsis: clinically useful? Curr. Opin. Crit. Care., 11(5), 5-473.
118. Gibot, S., Cravoisy, A., Levy, B., Bene, M.C., Faure, G., Bollaert, P.E. (2004). Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N. Engl. J. Med., 350(5), 5-451.
119. van der Meer, V., Neven, A.K., van den Broek, P.J., Assendelft, W.J. (2005). Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ., 331(7507), 26.
120. Tang, B.M., Eslick, G.D., Craig, J.C., McLean, A.S. (2007). Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet. Infect. Dis., 7(3), 3-210.
121. Wang, D.Y., Qin, R.Y., Liu, Z.R., Gupta, M.K., Chang, Q. (2004). Expression of TREM-1 mRNA in acute pancreatitis. World J. Gastroenterol., 10(18), 18-2744.
122. Koussoulas, V., Vassiliou, S., Demonakou, M., Tassias, G., Giamarellos-Bourboulis, E.J., Mouktaroudi, M., et al. (2006). Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease. Eur. J. Gastroenterol. Hepatol., 18(4), 4-375.
123. Cabie, A., Farkas, J.C., Fitting, C., Laurian, C., Cormier, J.M., Carlet, J., et al. (1993). High levels of portal TNF-alpha during abdominal aortic surgery in man. Cytokine., 5(5), 5-448.
124. Eichacker, P.Q P.C., Kalil, A., Esposito, C., Cui, X., Banks, S.M., Gerstenberger, E.P., Fitz, Y., Danner, R.L., Natanson, C. (2002). Risk and the efficacy of antiinflammatory agents:retrospective and confirmatory studies of sepsis. Am. J. Respir. Crit. Care. Med., 166(9), 9-1197.
125. Cuesta, N., Salkowski C.A., Thomas K.E., Vogel S.N. Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-2. J Immunol. 2003 Jun 1; 170(11), 5739-47.
126. Karaghiosoff M., Steinborn R., Kovarik P., Kriegshäuser G., Baccarini M., Donabauer B., Reichart U., Kolbe T., Bogdan C., Leanderson T., Levy D., Decker T., Müller M. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol. 2003 May; 4(5), 471-7. Epub 2003 Apr 7.
127. Peyssonnaux C., Cejudo-Martin P., Doedens A., Zinkernagel A.S., Johnson R.S., Nizet V. Cutting edge:Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol. 2007 Jun 15; 178(12), 7516-9.
128. Matsukawa A., Kaplan M.H., Hogaboam C.M., Lukacs N.W., Kunkel S.L. Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J ExpMed. 2001 Mar 19; 193(6), 679-88.
129. Lentsch A.B., Kato A., Davis B., Wang W., Chao C., Edwards M.J. STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia. J Clin Invest. 2001 Nov; 108(10), 1475-82.
130. Matsukawa A., Takeda K., Kudo S., Maeda T., Kagayama M., Akira S. Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils. J Immunol. 2003 Dec 1; 171(11), 6198-205.
131. Reimold A.M., Kim J., Finberg R., Glimcher L.H. Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice. Int Immunol. 2001 Feb; 13(2), 241-8.
132. Xiao X., Zuo X., Davis A.A., McMillan D.R., Curry B.B., Richardson J.A., Benjamin I.J. HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J. 1999 Nov 1; 18(21), 5943-52.
133. Gadjeva M., Tomczak M.F., Zhang M., Wang Y.Y., Dull K., Rogers A.B.,Erdman S.E., Fox J.G., Carroll M., Horwitz B.H. A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol. 2004 Nov 1; 173(9), 5786-93.